Zofran was approved by the U.S. Food and Drug Administration (FDA) to treat nausea and vomiting caused by chemotherapy and radiation. The drug was also prescribed to treat morning sickness in pregnant women, but it was not approved by the FDA for this use.
The Center for Birth Defects Research and Prevention recently published a study suggesting that women using Zofran during the first trimester of pregnancy had a significantly increased chance of having a child born with birth defects.
Zofran is believed to cause cleft lip, cleft palate, and congenital heart defects. Although Zofran was not approved by the FDA for morning sickness, GlaxoSmithKline promoted off-label use of the drug.
Mothers who took Zofran during pregnancy and had a child with cleft lip, cleft palate, or heart defects may be entitled to compensation. If you and your child have faced these issues, please call today to see if we can help.
When you call, please have answers to the following questions:
- Whether you were prescribed Zofran? Reason for prescription
- Did you have any preexisting conditions, allergies or contraindications for Zofran? Did you have congenital long QT syndrom
- What dosage were you prescribed? How often?